Cargando…

A Neonate with Mucopolysaccharidosis Type VII with Intractable Ascites

We report a case of a patient with severe fetal hydrops and refractory ascites, diagnosed as mucopolysaccharidosis type VII (MPS VII) by whole-exome sequencing, and discharged at 5 months of age after long-term ventilatory management. A male neonate was born by emergency cesarean section due to feta...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukui, Kana, Amari, Shoichiro, Yotani, Nobuyuki, Kosaki, Rika, Hata, Kenichiro, Kosuga, Motomichi, Sago, Haruhiko, Isayama, Tetsuya, Ito, Yushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical Publishers, Inc. 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019997/
https://www.ncbi.nlm.nih.gov/pubmed/36936745
http://dx.doi.org/10.1055/a-2028-7784
_version_ 1784908153093095424
author Fukui, Kana
Amari, Shoichiro
Yotani, Nobuyuki
Kosaki, Rika
Hata, Kenichiro
Kosuga, Motomichi
Sago, Haruhiko
Isayama, Tetsuya
Ito, Yushi
author_facet Fukui, Kana
Amari, Shoichiro
Yotani, Nobuyuki
Kosaki, Rika
Hata, Kenichiro
Kosuga, Motomichi
Sago, Haruhiko
Isayama, Tetsuya
Ito, Yushi
author_sort Fukui, Kana
collection PubMed
description We report a case of a patient with severe fetal hydrops and refractory ascites, diagnosed as mucopolysaccharidosis type VII (MPS VII) by whole-exome sequencing, and discharged at 5 months of age after long-term ventilatory management. A male neonate was born by emergency cesarean section due to fetal distress at 30 (1/7) weeks' gestation. Physical examination and X-rays revealed pleural effusion, ascites, and generalized edema, indicating severe fetal hydrops. He underwent tracheal intubation because of respiratory distress that was attributed to massive ascites, pulmonary hypoplasia, and pulmonary hypertension. He received mechanical ventilation and inhaled nitric oxide therapy. Prednisone, octreotide, and a factor XIII preparation were used as the treatment for ascites, and the ascites gradually decreased. He was extubated within 2 months of age. At 4 months of age, the results of whole-exome sequencing of the cord blood showed a compound heterozygous mutation in the GUSB gene, the gene responsible for MPS VII. Enzyme replacement therapy was initiated, and the ascites was resolved. Careful systemic management, including lung-protective respiratory management and the early establishment of nutrition, is important for the long-term survival of infants with fetal hydrops, and early aggressive workup, including whole-genome sequencing for the cause, should be performed in the case of refractory ascites.
format Online
Article
Text
id pubmed-10019997
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Thieme Medical Publishers, Inc.
record_format MEDLINE/PubMed
spelling pubmed-100199972023-03-17 A Neonate with Mucopolysaccharidosis Type VII with Intractable Ascites Fukui, Kana Amari, Shoichiro Yotani, Nobuyuki Kosaki, Rika Hata, Kenichiro Kosuga, Motomichi Sago, Haruhiko Isayama, Tetsuya Ito, Yushi AJP Rep We report a case of a patient with severe fetal hydrops and refractory ascites, diagnosed as mucopolysaccharidosis type VII (MPS VII) by whole-exome sequencing, and discharged at 5 months of age after long-term ventilatory management. A male neonate was born by emergency cesarean section due to fetal distress at 30 (1/7) weeks' gestation. Physical examination and X-rays revealed pleural effusion, ascites, and generalized edema, indicating severe fetal hydrops. He underwent tracheal intubation because of respiratory distress that was attributed to massive ascites, pulmonary hypoplasia, and pulmonary hypertension. He received mechanical ventilation and inhaled nitric oxide therapy. Prednisone, octreotide, and a factor XIII preparation were used as the treatment for ascites, and the ascites gradually decreased. He was extubated within 2 months of age. At 4 months of age, the results of whole-exome sequencing of the cord blood showed a compound heterozygous mutation in the GUSB gene, the gene responsible for MPS VII. Enzyme replacement therapy was initiated, and the ascites was resolved. Careful systemic management, including lung-protective respiratory management and the early establishment of nutrition, is important for the long-term survival of infants with fetal hydrops, and early aggressive workup, including whole-genome sequencing for the cause, should be performed in the case of refractory ascites. Thieme Medical Publishers, Inc. 2023-03-16 /pmc/articles/PMC10019997/ /pubmed/36936745 http://dx.doi.org/10.1055/a-2028-7784 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Fukui, Kana
Amari, Shoichiro
Yotani, Nobuyuki
Kosaki, Rika
Hata, Kenichiro
Kosuga, Motomichi
Sago, Haruhiko
Isayama, Tetsuya
Ito, Yushi
A Neonate with Mucopolysaccharidosis Type VII with Intractable Ascites
title A Neonate with Mucopolysaccharidosis Type VII with Intractable Ascites
title_full A Neonate with Mucopolysaccharidosis Type VII with Intractable Ascites
title_fullStr A Neonate with Mucopolysaccharidosis Type VII with Intractable Ascites
title_full_unstemmed A Neonate with Mucopolysaccharidosis Type VII with Intractable Ascites
title_short A Neonate with Mucopolysaccharidosis Type VII with Intractable Ascites
title_sort neonate with mucopolysaccharidosis type vii with intractable ascites
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019997/
https://www.ncbi.nlm.nih.gov/pubmed/36936745
http://dx.doi.org/10.1055/a-2028-7784
work_keys_str_mv AT fukuikana aneonatewithmucopolysaccharidosistypeviiwithintractableascites
AT amarishoichiro aneonatewithmucopolysaccharidosistypeviiwithintractableascites
AT yotaninobuyuki aneonatewithmucopolysaccharidosistypeviiwithintractableascites
AT kosakirika aneonatewithmucopolysaccharidosistypeviiwithintractableascites
AT hatakenichiro aneonatewithmucopolysaccharidosistypeviiwithintractableascites
AT kosugamotomichi aneonatewithmucopolysaccharidosistypeviiwithintractableascites
AT sagoharuhiko aneonatewithmucopolysaccharidosistypeviiwithintractableascites
AT isayamatetsuya aneonatewithmucopolysaccharidosistypeviiwithintractableascites
AT itoyushi aneonatewithmucopolysaccharidosistypeviiwithintractableascites
AT fukuikana neonatewithmucopolysaccharidosistypeviiwithintractableascites
AT amarishoichiro neonatewithmucopolysaccharidosistypeviiwithintractableascites
AT yotaninobuyuki neonatewithmucopolysaccharidosistypeviiwithintractableascites
AT kosakirika neonatewithmucopolysaccharidosistypeviiwithintractableascites
AT hatakenichiro neonatewithmucopolysaccharidosistypeviiwithintractableascites
AT kosugamotomichi neonatewithmucopolysaccharidosistypeviiwithintractableascites
AT sagoharuhiko neonatewithmucopolysaccharidosistypeviiwithintractableascites
AT isayamatetsuya neonatewithmucopolysaccharidosistypeviiwithintractableascites
AT itoyushi neonatewithmucopolysaccharidosistypeviiwithintractableascites